EXTON, Pa., November 28, 2016 – AGC Chemicals Americas, Inc. introduces Amolea AT2™, a fluorinated precision cleaning solvent that provides medical device manufacturers a safer, highly effective and environmentally friendly alternative to n-propyl bromide and trichloroethylene solvents. AGC will feature Amolea AT2 at the MD&M West Expo, Booth 3170, February 7-9, 2017 in Anaheim, California.
Amolea AT2 has no ozone depletion potential, low global warming potential and is non-flammable, enabling manufacturers to more easily meet increasingly strict environmental regulations. Using Amolea AT2 is energy efficient because of its low latent heat of vaporization.
Amolea AT2 demonstrates excellent solvency with a wide variety of press, cutting, silicone and refrigerant oils; greases; asphalt pitches; and fluxes used in the electronics industry. It is approved for use as a precision cleaner, defluxing agent, carrier solvent for silicone and fluorinated lubricants, and moisture displacement fluid.
“Amolea AT2 is an ideal cleaning solvent for medical device manufacturers because it lets them comply with environmental regulations more easily and helps them to improve worker health and safety,” said Jim Scott, AGC technical manager.
Amolea AT2 joins AGC’s AsahiKlin AE-3000 series of environmentally sensible fluorinated solvents, which were designed to replace halogenated solvents having unfavorable environmental properties.
AGC Chemicals Americas, Inc. is a wholly owned subsidiary of AGC, Inc., a $13 billion multinational corporation and one of the world’s largest manufacturers of glass, electronic displays and chemical products. The company was formed in 2004 through the merging of sister companies Asahi Glass Fluoropolymers USA and AGA Chemicals. Headquartered in Exton, Pa., AGC Chemicals Americas maintains manufacturing operations in nearby Thorndale, Pa., and warehouses located throughout North America.